Loading...
Loading...
Browse all stories on DeepNewz
VisitWhat rank will Neuralink's second patient, Alex, achieve in Counter-Strike 2 by end of 2024?
Top 10% Rank • 25%
Top 25% Rank • 25%
Top 50% Rank • 25%
Other • 25%
Neuralink official announcements or gaming community reports
Neuralink's Second Patient Uses Implant to Play Counter-Strike 2 and Design with Fusion 360
Aug 21, 2024, 10:55 PM
Neuralink has successfully implanted its brain chip into a second human participant, Alex, as part of its PRIME Study. The surgery was conducted at the Barrow Neurological Institute, and Alex was discharged the following day with a smooth recovery. The implant allows Alex to control digital devices using his thoughts, enabling him to play video games like Counter-Strike 2 and use computer-aided design (CAD) software, including Fusion 360. Neuralink has reported no issues with thread retraction, a problem that affected the first patient. Alex expressed his satisfaction with the technology, noting its impressive functionality. Remarkably, Alex broke the previous BCI Webgrid record on his first day.
View original story
Yes • 50%
No • 50%
Breaks another BCI Webgrid record • 25%
Wins a Counter-Strike 2 tournament • 25%
Designs a complex 3D object using CAD software • 25%
Other • 25%
Very Satisfied • 25%
Satisfied • 25%
Neutral • 25%
Dissatisfied • 25%
2024 • 25%
2025 • 25%
2026 • 25%
2027 or later • 25%
Successful with no issues • 25%
Successful with minor issues • 25%
Unsuccessful due to technical issues • 25%
Unsuccessful due to patient complications • 25%
2024 • 25%
2025 • 25%
2026 • 25%
Not by 2026 • 25%
Beginner • 25%
Intermediate • 25%
Advanced • 25%
Professional • 25%
Yes • 50%
No • 50%
Top-1 • 25%
Top-3 • 25%
Top-5 • 25%
Not in Top-5 • 25%
Top 10% • 25%
Top 25% • 25%
Top 50% • 25%
Below 50% • 25%
Top 10 in the world • 25%
Top 20 in the world • 25%
Top 50 in the world • 25%
Not in the top 50 • 25%
No • 50%
Yes • 50%
Yes • 50%
No • 50%
Video Editing Software • 25%
Drawing Software • 25%
Other • 25%
Music Production Software • 25%